| Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis G Gobbi, T Atkin, T Zytynski, S Wang, S Askari, J Boruff, M Ware, ... JAMA psychiatry 76 (4), 426-434, 2019 | 880 | 2019 |
| Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery T Atkin, S Comai, G Gobbi, EL Barker Pharmacological reviews 70 (2), 197-245, 2018 | 391 | 2018 |
| Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder T Atkin, N Nuñez, G Gobbi Journal of Child Psychology and Psychiatry 58 (8), 865-879, 2017 | 16 | 2017 |
| Lifelong reductions of PKMζ in ventral hippocampus of nonhuman primates exposed to early-life adversity due to unpredictable maternal care SL Fulton, C Hsieh, T Atkin, R Norris, E Schoenfeld, P Tsokas, AA Fenton, ... Learning & Memory 28 (9), 341-347, 2021 | 6 | 2021 |
| & Mayo, N.(2019). Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis G Gobbi, T Atkin, T Zytynski, S Wang, S Askari, J Boruff JAMA psychiatry, 0 | 5 | |
| Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms S Comai, N Nunez, T Atkin, MF Ghabrash, R Zakarian, A Fielding, ... BMC medicine 22 (1), 33, 2024 | 3 | 2024 |
| précis G Gobbi, T Atkin, T Zytynski Psychiatry, 2019 | | 2019 |
